Formulation evaluation and in vitro permeation studies of transdermal nifedipine from matrix type patches

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 6, Issue 1, 2014, Pages 185-188

  Arun Raj, R ^a  

^a MAHATMA GANDHI UNIVERSITY   (India)

Author keywords

Matrix type patches; Moulding technique; Nifedipine; Transdermal drug delivery

Indexed keywords

NIFEDIPINE; POLYMER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG RELEASE; DRUG SCREENING; DRUG STABILITY; EDEMA; ERYTHEMA; EXCIPIENT COMPATIBILITY; INFRARED SPECTROSCOPY; NONHUMAN; PATCH TEST; RABBIT; TRANSDERMAL PATCH;

EID: 84891938664     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Chickpetty SM, Raghavendra V Kulkarni, Hiremath Doddayya. Formulation: Transdermal therapeutic systems. Pharm. Form. & quality magazine. 2009 Aug 20.
2. Aqil M, Ali A, Sultana Y, Dubey K, Najmi AK, Pillai KK. In Vivo Characterization of Monolithic Matrix Type Transdermal Drug Delivery Systems of Pinacidil Monohydrate: A Technical Note. AAPS PharmSciTech. 2006; 7(1): Article 6.
3. Ubaidulla U, Reddy MVS, Ruckmani K, Ahmad FJ, and Khar RK. Transdermal Therapeutic System of Carvedilol: Effect of Hydrophilic and Hydrophobic Matrix on In Vitro and In Vivo Characteristics. AAPS PharmSciTech. 2007; 8 (1): Article 2.
4. Zhan X, Tang G, Chen S, Mao Z. A new copolymer membrane controlling clonidine linear release in a transdermal drug delivery system. Int. J. Pharm. 2006; 322: 1-5.
5. Grasela, John, inventor; Brown, Martin, Haller & McClain, LLP., Transdermal delivery of medications using a combination of penetration enhancers. US Patent 5837289.1998 Nov 17.
6. Indian Pharmacopoeia, 4th Ed. Vol. I: Controller of Publications, Ministryof Health & Family Welfare, Govt. of India, Delhi; 1996: 511-13.
7. Rajagopal Asraf, Arumugam, Formulation and evaluation of nimesulide transdermal patches. The Ind. Pharmacist. 2005; 4 (31):77-80.
8. Ramesh Gannu, Vamshi Vishnu Y, Kishan V, Madhusudan Rao Y. Development of Nitrendipine transdermal patches: In vitro and Ex vivo characterization. Current drug del. 2007; 4:69-76.
9. Jamakandi VG, Mulla JS, Vinay BL, Shivakumar HN. Formulation, characterization, and evaluation of matrix-type transdermal patches of a model antihypertensive drug. Asian J of pharm. 2009; 3(1):59-65.
10. Bagyalakshmi J, William AS, Mithun AW, Ravi TK, Manavalan R, Manna PK. Pharmacodynamics of ampicillin sodium transdermal patches in an in vitro infection model. Ind. J of Pharm. Sci. 2006; 68 (4):540-541.
11. Veena S Belgamwar, Mohit S Pandey, Dhiraj S Chauk, Sanjay J Surana. Pluronic lecithin organogel. Asian J of Pharm. 2008; 2(3): 134-138.
12. Jacobs W, Francone CA. Structure and function of skin. 2nd edition W. B Saunders Philadelphia: 1970; chapter-4.
13. Goldsmith LA. Biochemistry and physiology of skin Vols. I and II. Oxford university press, Newyork: 1983: 56-110.
14. Sonia Dhiman, Thakur Gurjeet Sing & Ashish Kumar Rehni. Transdermal patches: A recent approach to new drug delivery system. Int J Pharm Pharm Sci. 2011, 3(5): 26-34.
15. Sun TT, Green H. Differentiation of the epidermal Keratinocytes in cell culture: formation of the cornified envelope cell. Int. J of Pharm. Sci. 1976; 9:515-521.
16. Wertz PW, Downing DT. Glycolipids in mammalian epidermis structure and function in the water barrier. Science. 1982; 217:1261-1262.
17. Chien YW, Dev. Transdermal drug delivery System. Drug Dev and Ind. Pharm. 1987; 589-651.
18. Flynn GL. Percutaneous absorption. Bronaugh, and Maibach, eds. Marcel Dekker inc., Newyork: 1985; 17.
19. Ilel B, Schaefer H, Weipierre, Doucet O. Follicles play an important role in percutaneous absorption. J. Pharm. Sci. 1991; 80:424-428.
20. Treager RT. The permeability of mammalian skin to ions. J. Invest. Dermatol. 1966; 46:16-19.
21. Elias PM. The permeability of the skin physiol. Rev. 1971; 51: 702.
22. Chien YW. Transdermal Therapeutic Systems. Controlled Drug Delivery: Fundamentals and Applications, J.R. Robinson and V.H.L. Lee, Eds. Marcel Dekker, Inc., New York, NY: 2d ed., 1987: 523-552.
23. Wolff HM. Optimal Process Design for the Manufacturing of Transdermal Drug Delivery Systems. Pharm. S T Tech. 2000; 3 (5):173-181.
24. Katz M, Poulsen BJ. Absorption of drugs through the skin in hand book of experimental pharmacology. Springer-Verlag, New York: 1971; 28:103-174.
25. Lynch D, Roberts L Daynes. Skin immunology-The Achilles heal to transdermal to drug delivery. J Contr. release, 1987; 6: 39-50.
26. Hurksman, Bodde, Van Driel. Skin irritation caused by transdermal drug delivery systems during long term application. Br J Dermatol. 1985; 112: 461-467.
27. Rajesh N, Siddaramaiah, D.V. Gowda & Somashekar.C.N. Formulation and evaluation of biopolymer based transdermal drug delivery. Int J Pharm Pharm Sci. 2010, 2 (2): 142-147.